Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas
Open Access
- 1 October 2005
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 18 (10), 1329-1335
- https://doi.org/10.1038/modpathol.3800427
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomasLaboratory Investigation, 2004
- A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)British Journal of Cancer, 2003
- CpG island methylation in carcinoid and pancreatic endocrine tumorsOncogene, 2003
- Why the Epidermal Growth Factor Receptor? The Rationale for Cancer TherapyThe Oncologist, 2002
- Immunohistochemical expression of transforming growth factor α and epidermal growth factor receptor in pancreatic endocrine tumorsHuman Pathology, 2001
- Prognostic Significance of p27, Ki-67, and Topoisomerase IIα Expression in Clinically Nonfunctioning Pancreatic Endocrine TumorsEndocrine Pathology, 2000
- A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.JCI Insight, 1997
- Immunohistochemical Expression of Transforming Growth Factor Alpha and Epidermal Growth Factor Receptor in Gastrointestinal CarcinoidsThe American Journal of Surgical Pathology, 1997
- Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumoursInternational Journal of Cancer, 1995
- Expression of Growth Factors and Their Receptors in Neuroendocrine Gut and Pancreatic Tumors, and Prognostic Factors for SurvivalAnnals of the New York Academy of Sciences, 1994